Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DETACT pilot study of dupilumab in severe asthma
2024-517567-23-00Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Feb 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dupilumab in severe asthma, sponsored by Medical University of Vienna. Primary endpoint: Effect of dupilumab on airway mucus plugging. Started Feb 2023; status: completed.
02
Drugs
03
Conditions
severe asthma
Beyond the preview
Go deeper on 2024-517567-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517567-23-00.